Catalyst Pharmaceuticals
CPRX
#3568
Rank
โ‚ฌ2.48 B
Marketcap
20,40ย โ‚ฌ
Share price
2.30%
Change (1 day)
43.96%
Change (1 year)

Revenue for Catalyst Pharmaceuticals (CPRX)

Revenue in 2024 (TTM): โ‚ฌ0.45 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.43 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ0.36 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Catalyst Pharmaceuticals from 2009 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ0.47 B31.18%
2023 โ‚ฌ0.36 B80.39%
2022 โ‚ฌ0.19 B60.58%
2021 โ‚ฌ0.12 B28.45%
2020 โ‚ฌ96.8 M6%
2019 โ‚ฌ91.32 M20795.34%
2018 โ‚ฌ0.43 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A-100%
2010 โ‚ฌ0.36 M
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ2.51 B 480.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.67 B 286.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ78.38 B 17,962.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.10 B-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.14 B 12,839.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ37.02 B 8,431.04%๐Ÿ‡บ๐Ÿ‡ธ USA